Status:
ACTIVE_NOT_RECRUITING
An Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial
Lead Sponsor:
University of Arizona
Collaborating Sponsors:
National Cancer Institute (NCI)
University of California, Los Angeles
Conditions:
HPV-associated Cancer
Eligibility:
All Genders
Brief Summary
This is an extended follow-up study to follow-up study participants who received 1 booster dose of Gardasil 9 in the "HPV vaccine delayed booster trial." This was a prospective, single-arm, open-label...
Eligibility Criteria
Inclusion
- Study participants who received one booster dose of Gardasil 9 at month 24 and elected not to receive the second booster at month 30 in the original "HPV vaccine delayed booster trial"
- Ability to understand and the willingness to sign a written informed consent document by the legal representative(s) of the participant.
- Ability to understand and the willingness to sign a written assent document by the participant.
Exclusion
- \- Has received any HPV vaccine dose from an external source at any point during or after participation in the HPV vaccine delayed booster trial.
Key Trial Info
Start Date :
November 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT04688476
Start Date
November 17 2020
End Date
December 1 2025
Last Update
October 16 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona
Tucson, Arizona, United States, 85724
2
University of California, Los Angeles
Los Angeles, California, United States, 90095